Concepedia

Ann Verheyen

AV

Statistics

Publications

9

Citations

266

H-Index

9

Active since

2009

Affiliations

Janssen (Belgium)(Current)

Ghent University

Kwame Nkrumah University of Science and Technology

University of Indonesia

Kumasi Centre for Collaborative Research in Tropical Medicine

Ann Verheyen is an author at Janssen (Belgium) specializing in infectious diseases, life sciences, and molecular virology.

Publications per year

2009–2020

9

Publications

9

Susceptibility of Human Immunodeficiency Virus Type 1 to the Maturation Inhibitor Bevirimat Is Modulated by Baseline Polymorphisms in Gag Spacer Peptide 1

Kurt Van Baelen, Karl Salzwedel, Evelien Rondelez et al. · Antimicrobial Agents and Chemotherapy · 2009 · 88 citations · Full text

, , +17

Cross-Resistance Profile Determination of Two Second-Generation HIV-1 Integrase Inhibitors Using a Panel of Recombinant Viruses Derived from Raltegravir-Treated Clinical Isolates

Liesbeth Van Wesenbeeck, Evelien Rondelez, Maxim Feyaerts et al. · Antimicrobial Agents and Chemotherapy · 2010 · 53 citations · Full text

, , +17

Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor

Olivia Goethals, Marcia Van Ginderen, Ann Vos et al. · Antiviral Research · 2011 · 32 citations

, , +14

Detection of Ascaris lumbricoides infection by ABA-1 coproantigen ELISA

Ole Lagatie, Ann Verheyen, Kim Van Hoof et al. · PLoS neglected tropical diseases · 2020 · 20 citations · Full text

, , +17

Proof-of-Concept Rapid Diagnostic Test for Onchocerciasis: Exploring Peptide Biomarkers and the Use of Gold Nanoshells as Reporter Nanoparticles

María J. González‐Moa, Bieke Van Dorst, Ole Lagatie et al. · ACS Infectious Diseases · 2018 · 18 citations · Full text

, , +17

1–5 of 9